|Bid||66.37 x 100|
|Ask||67.61 x 200|
|Day's Range||67.66 - 70.44|
|52 Week Range||54.66 - 84.88|
|PE Ratio (TTM)||12.09|
|Earnings Date||Apr 30, 2018 - May 4, 2018|
|Forward Dividend & Yield||1.85 (2.67%)|
|1y Target Est||74.31|
McKesson and Cardinal Health are alleged to have sent more than 12 million opioid doses to a single pharmacy in West Virginia over an eight-year period, according to a House committee probe.
believe that many investors under-appreciate Sanofi’s non-diabetes businesses and think that the strength from the rest of the company will provide plenty of opportunity for upside, including the new acquisitions and pipeline. The recent slide in shares makes SNY an attractive purchase in our eyes.
Bridgewater Associates, the firm of hedge fund billionaire Ray Dalio, took large positions in ETFs, 13F filings show.
Stocks that moved substantially or traded heavily on Tuesday: AmerisourceBergen Corp., up $8.32 to $97.77 The Wall Street Journal said Walgreens Boots Alliance is interested in buying the rest of the prescription ...
A possible Walgreens buy of AmerisourceBergen as well as the latest Amazon rumor threaten to upend drug and medical supplies distribution.
Shares of health-care distributors fell Tuesday on news the sector could experience more consolidation and heightened competition from retail giant Amazon.com Inc.
The number of lawsuits has climbed past 350 from government entities suing Cardinal Health Inc., other health-care distributors and pharmaceutical manufacturers over the cost of battling the opioid addiction crisis. Settlement talks are ongoing for about 300 of those filed in federal instead of state courts. The cases have been consolidated before U.S. District Judge Dan Polster in Cleveland.
Cardinal Health has replaced the CEO of its medical supplies and services division, who left for a new job. Don Casey, who held the role for nearly six years, left the company because he was hired as CEO of Dentsply Sirona Inc. (XRAY), a York, Pennsylvania-based manufacturer of dental products and technologies. Jon Giacomin replaced him as CEO of the medical segment, according to a regulatory filing .
Cardinal Health's quarterly profit topped analysts' estimates as the U.S. drug distributor benefited from its purchase of Medtronic Plc's patient care business and a tie-up with drugstore chain CVS Health ...
Cardinal Health Inc. reported second-quarter profit and revenue beats early Thursday. Earnings for the latest quarter rose to $1.1 billion, or $3.33 per share, from $324 billion, or $1.02 per share in ...
Cardinal Health said on Thursday its quarterly profit more than tripled due to a benefit related to recent changes in U.S. tax laws. Net earnings attributable to the company was $1.05 billion, or $3.33 ...
- Revenue increases 6 percent to $35.2 billion . - GAAP(1) operating earnings declines 26 percent to $399 million , and GAAP diluted earnings per share (EPS) increases 226 percent to $3.33 . Among other ...
DUBLIN, Ohio, Feb. 7, 2018 /PRNewswire/ -- Cardinal Health (CAH) today announced that its board of directors has elected Akhil Johri, Executive Vice President and Chief Financial Officer of United Technologies, to the Cardinal Health board, effective today. In addition, Johri has been named to the board's Audit Committee. "We are thrilled to welcome Akhil to the board and believe that his financial expertise and broad global business background and insight will serve to further strengthen our already robust board of directors," said George Barrett, Executive Chairman of the Cardinal Health Board of Directors.
DUBLIN, Ohio , Feb. 7, 2018 /PRNewswire/ -- Cardinal Health (NYSE:CAH) today announced that its board of directors approved a regular quarterly dividend of $0.4624 per share, payable April 15, 2018 to ...
Here we look at the major factors that are likely to influence the earnings results of a few MedTech bigwigs within the broader Medical universe.
Thermo Fisher's (TMO) acquisition of FEI Company already adds capabilities to its analytical instruments portfolio. Also, solid cash in hand enables the company to yield fat returns to investors.